✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Ambalal Sarabhai Enterprises Ltd.

AMBALALSA

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹250 Cr.
P/E
19.53

Ambalal Sarabhai Enterprises Ltd.

  • Ambalal Sarabhai Ent
  • Balaxi Pharma.
  • Gennex Lab

FAQs on Ambalal Sarabhai Enterprises Ltd. Shareprice

Ambalal Sarabhai Ent has given lower returns compared to its competitors.
Ambalal Sarabhai Ent has grown at ~3.45% over the last 3yrs while peers have grown at a median rate of 14.56%

Ambalal Sarabhai Ent is not expensive.
Latest PE of Ambalal Sarabhai Ent is 19.94, while 3 year average PE is 32.25.
Also latest EV/EBITDA of Ambalal Sarabhai Ent is 33.47 while 3yr average is 41.7.

View FAQ's On Business

Growth Table

  • Ambalal Sarabhai Enterprises Ltd.
  • Balaxi Pharma.
  • Gennex Lab

Balance Sheet

  • Ambalal Sarabhai Enterprises Ltd.
  • Balaxi Pharma.
  • Gennex Lab

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Ambalal Sarabhai Enterprises Ltd.
  • Balaxi Pharma.
  • Gennex Lab

Cash Flow

  • Ambalal Sarabhai Enterprises Ltd.
  • Balaxi Pharma.
  • Gennex Lab

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Ambalal Sarabhai Enterprises Ltd.
  • Balaxi Pharma.
  • Gennex Lab

Quarterly Results

  • Ambalal Sarabhai Enterprises Ltd.
  • Balaxi Pharma.
  • Gennex Lab

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Ambalal Sarabhai Enterprises Ltd. Financials

Balance sheet of Ambalal Sarabhai Ent is moderately strong, But short term working capital might become an issue for this company.

Yes, The net debt of Ambalal Sarabhai Ent is increasing.
Latest net debt of Ambalal Sarabhai Ent is ₹25.61 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹20.67 Crs.

The profit is oscillating.
The profit of Ambalal Sarabhai Ent is ₹11.83 Crs for TTM, ₹4.93 Crs for Mar 2025 and ₹5.68 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Ambalal Sarabhai Ent latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech